Related Experiment Video
Updated: Apr 4, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Endometriosis, Anxiety, Allergic Rhinoconjunctivitis, and Asthma: A Population-Based Study
Hormoz Nassiri Kigloo1,2, Eva Suarthana3, Tina C Montreuil4,5
1Department of Obstetrics and Gynecology, McGill University, Montréal, Québec, Canada.
Objectives:
The objectives of the study were to evaluate the association between endometriosis, anxiety, allergic rhinoconjunctivitis, and asthma in hospitalized women and to determine the role of age.
Design:
A cross-sectional study using inpatient hospital discharge data from 2007 to 2014 was conducted. Participants/Materials: The study included 12,814,970 hospitalized women aged 18-49 years from the Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample (NIS) in the USA. Diagnoses of asthma, allergic rhinoconjunctivitis, endometriosis, and anxiety were identified using ICD-9 codes.
Setting:
The study was conducted at US community hospitals in the HCUP NIS database between 2007 and 2014.
Methods:
Of the 12,814,970 patients hospitalized between 2007 and 2014, 1,042,015 (8.1%) had asthma, 50,867 (0.4%) had allergic rhinoconjunctivitis, 831,239 (6.5%) had anxiety without endometriosis, 85,990 (0.7%) had endometriosis without anxiety, and 8,880 (0.1%) had both anxiety and endometriosis. Multivariable logistic regression models were used to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between endometriosis, anxiety, and asthma, adjusting for age, race, insurance type, smoking, obesity, hypertension, diabetes, thyroid disease, dyslipidemia, atherosclerosis, and depression. Analyses were stratified by age groups (18-34 and 18-49 years).
Results:
Among hospitalized women aged 18-49 and 18-34 years, the coexistence of anxiety and endometriosis was associated with the highest odds of asthma and allergic rhinoconjunctivitis. For asthma, adjusted ORs were 2.07 (95% CI: 1.94-2.20) among patients aged 18-49 years and 2.57 (2.35-2.81) in patients aged 18-34 years. The ORs for allergic rhinoconjunctivitis were 2.78 (2.30-3.36) and 3.45 (2.55-4.66), respectively. Anxiety or endometriosis alone was also significantly associated with both conditions.
Limitations:
The study used administrative data lacking information on disease severity, outpatient diagnoses, and treatment details. As a cross-sectional study, it cannot establish causality or temporal relationships.
Conclusions:
Endometriosis and anxiety were independently associated with asthma and allergic rhinoconjunctivitis, with stronger associations in women under 35 years. The combination of both conditions was associated with the highest likelihood of asthma and allergic rhinoconjunctivitis, suggesting a potential synergistic effect. Given the nature of the study, future research is needed to explore the shared inflammatory mechanisms. Our findings support clinical awareness of related inflammatory and psychological comorbidities when managing asthma, allergic rhinoconjunctivitis, or endometriosis.
More Related Videos
06:08Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
Related Concept Videos
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...